Dozens of tech companies are pushing their remote monitoring service to primary care doctors as a way to keep tabs on patients with chronic illnesses and free up appointment time.

Paris-based Cardiologs has a software platform to screen for arrhythmias from ECG data. It would add to Philips' portfolio of cardiac software for hospitals and remote monitoring.

BioIntelliSense, a startup with backers including UCHealth and Royal Philips, recently raised $45 million. The company began marketing its sticker-like device to monitor patients’ vitals last year after getting FDA clearance at the end of 2019.

MD+DI checked in with a few medical device technology experts for our review of 2020 and a look ahead to 2021. Read on for their perspectives.

Though the rest of 2020 is still unknown, one fact is very clear: Clinicians will need to continue to lean heavily on technology like RPM, AI and telehealth to ensure successful patient outcomes across the board.

Teladoc (NYSE: TDOC), the multi-billion dollar market leader in telemedicine, has agreed to purchase Livongo (NDAQ: LVGO), the multi-billion dollar market leader in remote patient monitoring for $18.5 billion, creating the market’s first $38 billion full-stack virtual health company.

After Withings co-founder Eric Carreel bought the connected device company back from Nokia two years ago, the company has charted a more clinical course. With $60 million in new funding, Withings plans to build out a remote monitoring program for its medical devices.